Dr.Rohit Soni

Dr.Rohit Soni was previously engaged with leading Indian companies like SUN PHARMA, LUPIN, ZYDUS CADILA, and ALEMBIC where he was responsible for the generic process development of Active Pharmaceutical ingredients(API) and their intermediates for regulated as well as non-regulated market. He was leading a team of more than 20 Scientists. Later, he got an exposure of Overseas assignment; he was associated with a European MNC named PHARMATHEN where he was “Head-Business Unit (API Operations) in Greece. He established and headed Indian Operations of PHARMATHEN Named “Adventus laboratories India private limited” situated in Vadodara-India.

He developed non-infringing processes for several API and intermediates and successfully implemented them on plant scale for commercial requirement. In his credit, he has 21 patents and 4 Publications. His core strength is a non-infringing and alternate synthesis to make the process robust, feasible, and economical on an Industrial scale. He has exposure to Macrolides, Peptides, Cephalosporins, and several synthetic APIs. His more than 30 years of experience in generic API development brings technical, managerial, inter-personnel, and commercial skills to the company’s reputation.